CAR T-CELL THERAPY
Clinical trials for CAR T-CELL THERAPY explained in plain language.
Never miss a new study
Get alerted when new CAR T-CELL THERAPY trials appear
Sign up with your email to follow new studies for CAR T-CELL THERAPY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Can a common vaccine protect the most vulnerable?
⭐️ VACCINE ⭐️ Not yet recruitingThis study is checking if the RSV vaccine Abrysvo can trigger a protective immune response in adults with blood cancers who have had a stem cell transplant or CAR-T therapy. Researchers will measure antibody levels in the blood before the shot and again four weeks and six months …
Matched conditions: CAR T-CELL THERAPY
Phase: PHASE4 • Sponsor: The Cooper Health System • Aim: ⭐️ VACCINE ⭐️
Last updated Mar 11, 2026 14:53 UTC
-
One-Shot cancer treatment? new CAR-T therapy skips lab, aims to slash cost
Disease control Not yet recruitingThis early-stage study is testing a new type of CAR-T cell therapy designed to be simpler and potentially cheaper. It aims to treat adults and teens with B-cell leukemia or lymphoma that has returned or not responded to standard treatments. Instead of modifying a patient's cells …
Matched conditions: CAR T-CELL THERAPY
Phase: PHASE1 • Sponsor: Qi deng • Aim: Disease control
Last updated Mar 24, 2026 12:02 UTC
-
New immune cell therapy targets stubborn MS in early human trial
Disease control Not yet recruitingThis early-stage trial is testing a new treatment called MB-CART 2019.1 for people with multiple sclerosis (MS) that continues to get worse despite standard medications. The study will first check if the treatment is safe and find the right dose, then see if it can stop all signs…
Matched conditions: CAR T-CELL THERAPY
Phase: PHASE1, PHASE2 • Sponsor: Miltenyi Biomedicine GmbH • Aim: Disease control
Last updated Mar 23, 2026 15:20 UTC
-
Scientists probe CAR-T's hidden toll on the brain
Knowledge-focused Not yet recruitingThis study aims to understand why some patients experience brain inflammation and thinking problems after receiving CAR-T cell therapy for cancer. Researchers will observe 10 high-risk patients, using brain scans and cognitive tests before, during, and after treatment to measure …
Matched conditions: CAR T-CELL THERAPY
Sponsor: Karolinska University Hospital • Aim: Knowledge-focused
Last updated Mar 31, 2026 12:11 UTC
-
Which cancer treatment feels worse? study tracks patient suffering
Knowledge-focused Not yet recruitingThis study aims to understand and compare how patients feel during two advanced cancer treatments: stem cell transplants and CAR-T therapy. Researchers will follow 162 patients with blood cancers through their hospital stays, asking them to report their symptoms and quality of li…
Matched conditions: CAR T-CELL THERAPY
Sponsor: Associazione Qol-one • Aim: Knowledge-focused
Last updated Mar 19, 2026 14:56 UTC
-
15-Year watch begins for gene therapy side effects
Knowledge-focused Not yet recruitingThis study aims to track the long-term safety of gene therapy treatments developed by Seattle Children's Hospital. It will follow up to 500 patients for 15 years after their treatment to check for any delayed side effects and see how well the therapy lasts over time. No new treat…
Matched conditions: CAR T-CELL THERAPY
Sponsor: Seattle Children's Hospital • Aim: Knowledge-focused
Last updated Mar 10, 2026 12:53 UTC